A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications

D. W. Metry, A. N. Haggstrom, B. A. Drolet, E. Baselga, S. Chamlin, M. Garzon, K. Horii, A. Lucky, A. J. Mancini, B. Newell, A. Nopper, G. Heyer, L. J. Frieden

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

PHACE (OMIM no. 606519) is a neurocutaneous syndrome that refers to the association of large, plaque-like, "segmental" hemangiomas of the face, with one or more of the following anomalies: posterior fossa brain malformations, arterial cerebrovascular anomalies, cardiovascular anomalies, eye anomalies, and ventral developmental defects, specifically sternal defects and/or supraumbilical raphe. The etiology and pathogenesis of PHACE is unknown, and potential risk factors for the syndrome have not been systematically studied. The purpose of this study was thus to determine (1) the incidence of PHACE and associated anomalies among a large cohort of hemangioma patients, (2) whether certain demographic, prenatal or perinatal risk factors predispose infants to this syndrome, and (3) whether the cutaneous distribution of the hemangioma can be correlated to the types of anomalies present. We undertook a prospective, cohort study of 1,096 children with hemangiomas, 25 of whom met criteria for PHACE. These 25 patients represented 20% of infants with segmental facial hemangiomas. Compared to previous reports, our PHACE patients had a higher incidence of cerebrovascular and cardiovascular anomalies. Two developed acute arterial ischemic stroke during infancy, while two with cardiovascular anomalies showed documented evidence of normalization, suggesting that both progressive and regressive vascular phenomena may occur in this syndrome. Correlation to the anatomic location of the hemangioma appears to be helpful in determining which structural abnormalities might be present. A comparison of demographic and perinatal data between our PHACE cases and the hemangioma cohort overall showed no major differences, except a trend for PHACE infants to be of slighter higher gestational age and born to slightly older mothers. Eighty-eight percent were female, a finding which has been noted in multiple other reports. Further research is needed to determine possible etiologies, optimal evaluation, and outcomes.

Original languageEnglish (US)
Pages (from-to)975-986
Number of pages12
JournalAmerican Journal of Medical Genetics
Volume140 A
Issue number9
DOIs
StatePublished - May 1 2006

Fingerprint

Hemangioma
Demography
Prospective Studies
Neurocutaneous Syndromes
Genetic Databases
Incidence
Gestational Age
Blood Vessels
Cohort Studies
Stroke
Mothers
Skin
Brain
Research

Keywords

  • Hemangioma
  • PHACE
  • PHACES
  • Pediatric stroke

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A prospective study of PHACE syndrome in infantile hemangiomas : Demographic features, clinical findings, and complications. / Metry, D. W.; Haggstrom, A. N.; Drolet, B. A.; Baselga, E.; Chamlin, S.; Garzon, M.; Horii, K.; Lucky, A.; Mancini, A. J.; Newell, B.; Nopper, A.; Heyer, G.; Frieden, L. J.

In: American Journal of Medical Genetics, Vol. 140 A, No. 9, 01.05.2006, p. 975-986.

Research output: Contribution to journalArticle

Metry, DW, Haggstrom, AN, Drolet, BA, Baselga, E, Chamlin, S, Garzon, M, Horii, K, Lucky, A, Mancini, AJ, Newell, B, Nopper, A, Heyer, G & Frieden, LJ 2006, 'A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications', American Journal of Medical Genetics, vol. 140 A, no. 9, pp. 975-986. https://doi.org/10.1002/ajmg.a.31189
Metry, D. W. ; Haggstrom, A. N. ; Drolet, B. A. ; Baselga, E. ; Chamlin, S. ; Garzon, M. ; Horii, K. ; Lucky, A. ; Mancini, A. J. ; Newell, B. ; Nopper, A. ; Heyer, G. ; Frieden, L. J. / A prospective study of PHACE syndrome in infantile hemangiomas : Demographic features, clinical findings, and complications. In: American Journal of Medical Genetics. 2006 ; Vol. 140 A, No. 9. pp. 975-986.
@article{10ad0b128d7847248cab4f86e42508f3,
title = "A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complications",
abstract = "PHACE (OMIM no. 606519) is a neurocutaneous syndrome that refers to the association of large, plaque-like, {"}segmental{"} hemangiomas of the face, with one or more of the following anomalies: posterior fossa brain malformations, arterial cerebrovascular anomalies, cardiovascular anomalies, eye anomalies, and ventral developmental defects, specifically sternal defects and/or supraumbilical raphe. The etiology and pathogenesis of PHACE is unknown, and potential risk factors for the syndrome have not been systematically studied. The purpose of this study was thus to determine (1) the incidence of PHACE and associated anomalies among a large cohort of hemangioma patients, (2) whether certain demographic, prenatal or perinatal risk factors predispose infants to this syndrome, and (3) whether the cutaneous distribution of the hemangioma can be correlated to the types of anomalies present. We undertook a prospective, cohort study of 1,096 children with hemangiomas, 25 of whom met criteria for PHACE. These 25 patients represented 20{\%} of infants with segmental facial hemangiomas. Compared to previous reports, our PHACE patients had a higher incidence of cerebrovascular and cardiovascular anomalies. Two developed acute arterial ischemic stroke during infancy, while two with cardiovascular anomalies showed documented evidence of normalization, suggesting that both progressive and regressive vascular phenomena may occur in this syndrome. Correlation to the anatomic location of the hemangioma appears to be helpful in determining which structural abnormalities might be present. A comparison of demographic and perinatal data between our PHACE cases and the hemangioma cohort overall showed no major differences, except a trend for PHACE infants to be of slighter higher gestational age and born to slightly older mothers. Eighty-eight percent were female, a finding which has been noted in multiple other reports. Further research is needed to determine possible etiologies, optimal evaluation, and outcomes.",
keywords = "Hemangioma, PHACE, PHACES, Pediatric stroke",
author = "Metry, {D. W.} and Haggstrom, {A. N.} and Drolet, {B. A.} and E. Baselga and S. Chamlin and M. Garzon and K. Horii and A. Lucky and Mancini, {A. J.} and B. Newell and A. Nopper and G. Heyer and Frieden, {L. J.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1002/ajmg.a.31189",
language = "English (US)",
volume = "140 A",
pages = "975--986",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - A prospective study of PHACE syndrome in infantile hemangiomas

T2 - Demographic features, clinical findings, and complications

AU - Metry, D. W.

AU - Haggstrom, A. N.

AU - Drolet, B. A.

AU - Baselga, E.

AU - Chamlin, S.

AU - Garzon, M.

AU - Horii, K.

AU - Lucky, A.

AU - Mancini, A. J.

AU - Newell, B.

AU - Nopper, A.

AU - Heyer, G.

AU - Frieden, L. J.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - PHACE (OMIM no. 606519) is a neurocutaneous syndrome that refers to the association of large, plaque-like, "segmental" hemangiomas of the face, with one or more of the following anomalies: posterior fossa brain malformations, arterial cerebrovascular anomalies, cardiovascular anomalies, eye anomalies, and ventral developmental defects, specifically sternal defects and/or supraumbilical raphe. The etiology and pathogenesis of PHACE is unknown, and potential risk factors for the syndrome have not been systematically studied. The purpose of this study was thus to determine (1) the incidence of PHACE and associated anomalies among a large cohort of hemangioma patients, (2) whether certain demographic, prenatal or perinatal risk factors predispose infants to this syndrome, and (3) whether the cutaneous distribution of the hemangioma can be correlated to the types of anomalies present. We undertook a prospective, cohort study of 1,096 children with hemangiomas, 25 of whom met criteria for PHACE. These 25 patients represented 20% of infants with segmental facial hemangiomas. Compared to previous reports, our PHACE patients had a higher incidence of cerebrovascular and cardiovascular anomalies. Two developed acute arterial ischemic stroke during infancy, while two with cardiovascular anomalies showed documented evidence of normalization, suggesting that both progressive and regressive vascular phenomena may occur in this syndrome. Correlation to the anatomic location of the hemangioma appears to be helpful in determining which structural abnormalities might be present. A comparison of demographic and perinatal data between our PHACE cases and the hemangioma cohort overall showed no major differences, except a trend for PHACE infants to be of slighter higher gestational age and born to slightly older mothers. Eighty-eight percent were female, a finding which has been noted in multiple other reports. Further research is needed to determine possible etiologies, optimal evaluation, and outcomes.

AB - PHACE (OMIM no. 606519) is a neurocutaneous syndrome that refers to the association of large, plaque-like, "segmental" hemangiomas of the face, with one or more of the following anomalies: posterior fossa brain malformations, arterial cerebrovascular anomalies, cardiovascular anomalies, eye anomalies, and ventral developmental defects, specifically sternal defects and/or supraumbilical raphe. The etiology and pathogenesis of PHACE is unknown, and potential risk factors for the syndrome have not been systematically studied. The purpose of this study was thus to determine (1) the incidence of PHACE and associated anomalies among a large cohort of hemangioma patients, (2) whether certain demographic, prenatal or perinatal risk factors predispose infants to this syndrome, and (3) whether the cutaneous distribution of the hemangioma can be correlated to the types of anomalies present. We undertook a prospective, cohort study of 1,096 children with hemangiomas, 25 of whom met criteria for PHACE. These 25 patients represented 20% of infants with segmental facial hemangiomas. Compared to previous reports, our PHACE patients had a higher incidence of cerebrovascular and cardiovascular anomalies. Two developed acute arterial ischemic stroke during infancy, while two with cardiovascular anomalies showed documented evidence of normalization, suggesting that both progressive and regressive vascular phenomena may occur in this syndrome. Correlation to the anatomic location of the hemangioma appears to be helpful in determining which structural abnormalities might be present. A comparison of demographic and perinatal data between our PHACE cases and the hemangioma cohort overall showed no major differences, except a trend for PHACE infants to be of slighter higher gestational age and born to slightly older mothers. Eighty-eight percent were female, a finding which has been noted in multiple other reports. Further research is needed to determine possible etiologies, optimal evaluation, and outcomes.

KW - Hemangioma

KW - PHACE

KW - PHACES

KW - Pediatric stroke

UR - http://www.scopus.com/inward/record.url?scp=33646115451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646115451&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.31189

DO - 10.1002/ajmg.a.31189

M3 - Article

C2 - 16575892

AN - SCOPUS:33646115451

VL - 140 A

SP - 975

EP - 986

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -